Why South Korea’s President Admits to Purchasing 360 Viagra Pills

Why South Korea’s President Admits to Purchasing 360 Viagra PillsWhy South Korea’s President Admits to Purchasing 360 Viagra Pills
undefined
Ryan General
November 23, 2016
The South Korean Office of the President has admitted that it acquired several erectile dysfunction pills after an opposition lawmaker made an exposé about the bizarre purchase.
In a statement, President Park Geun-hye’s office confirmed that it purchased about 360 Viagra pills and other similar drugs in December last year, reported.
The initial report became a trending topic on local social media, generating much speculation and intrigue from South Korean netizens. Park’s office however explained that the pills were intended to treat altitude sickness for presidential employees who were part of the president’s trips to Ethiopia, Uganda and Kenya. Doctors in South Korea usually prescribe Viagra and other similar drugs to climbers believing that such medicines are effective in treating discomfort and sickness caused by high altitudes.
President Park’s spokesperson Jung Youn-kuk further clarified that the pills were not even used.
The timing of the Viagra revelation, however, couldn’t have come at a worse time for the president as she is currently facing a political scandal.
Opposition parties, joined by some members of her own party are pushing a call for her impeachment due to allegations of letting a confidante manipulate government affairs while gaining ill-gotten wealth.
In connection with the scandal, South Korean tech giant Samsung offices were also recently raided by government officers as part of an investigation linking the company to the allegations against the president. Samsung allegedly bribed Park’s confidant Choi Soon-Sil last year to acquire state approval for a controversial and illegal merger.
Members of the political opposition have alleged that the president had knowledge and direct involvement with Choi’s criminal activities.
Share this Article
NextShark.com
© 2024 NextShark, Inc. All rights reserved.